Ascendis Pharma A/S (ASND) Q1 2024 Earnings

2MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-3.13
-2.64
-2.15
-1.66

Details

Expected EPS
N/A
Actual EPS
-2.5
Surprise EPS
-2.5
Surprise Percent
+∞%

Description

Ascendis Pharma A/S (ASND) has reported earnings of -2.5 per share for Q1 2024.

0 Comments

Share your thoughts